Extremely rare gene variants point to a potential cause of age-related macular degeneration
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
-
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
WHO certified Azerbaijan and Tajikistan as malaria-free
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
-
Biology | CDC | Disease | Non-Profit Research | Therapeutics
CDC reported increasing threat of spread of antimicrobial-resistant fungus in healthcare facilities
On Mar. 20, 2023, the Centers for Disease Control and Prevention (CDC) reported that Candida auris (C. auris),…
-
FDA approved first treatment for Rett syndrome
On Mar. 13, 2023, the U.S. Food and Drug Administration (FDA) announced that it had approved Acadia Pharmaceuticals’…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
-
Biotechnology | Diagnostics | Disease | Medical Device | Nanotechnology | Non-Profit Research | Therapeutics
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
-
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
-
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
-
Agriculture | Biotechnology | Cartoons - Original | COVID-19 | CRISPR | Diagnostics | Disease | FDA | Genomics | Life Science History | Therapeutics | USDA
Milestones in CRISPR
The Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
-
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
-
Biotechnology | CRISPR | Disease | Prehistory | Therapeutics
2.6 billion-year-old ancestors of the CRISPR gene-editing tool resurrected
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
-
CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
-
FDA approved first gene therapy to treat adults with Hemophilia B
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
-
Biotechnology | Diagnostics | Disease | Neurology | NIH | Therapeutics
NIH researchers unlocked pattern of gene activity for ADHD
On Nov. 16, 2022, researchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
-
Biotechnology | COVID-19 | Diagnostics | Disease | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
-
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
-
Study confirmed safety of shingles vaccine
On Oct. 20, 2022, published results supported previous findings that the recombinant zoster vaccine Shingrix, recommended by the…
-
DNA evidence of plague found in Central Asia
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
-
Biotechnology | Disease | WHO
WHO launched new initiative to stop the spread of invasive malaria vector in Africa
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
-
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Medicine | Nanotechnology | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Biotechnology & Biomanufacturing Initiative
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
-
Biotechnology | Diagnostics | Disease | Vaccine | WHO
Malaria booster vaccine showed durable high efficacy in African children, meeting WHO-specified 75% efficacy goal
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
-
Researchers in China reported embryos with DNA from three people develop normally in first safety study
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
-
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
-
First gene therapy for adults with severe hemophilia A, BioMarin’s ROCTAVIAN, approved by EC
On Aug. 24, 2022, BioMarin Pharmaceutical announced that the European Commission (EC) has granted conditional marketing authorization (CMA)…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
